Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel T Chang

Showing results (181-190 of 224) with videos related to

Pageof 23
Sort By:
Practical Radiation Oncology|July 10, 2024
SBRT for Pancreatic Cancer: A Radiosurgery Society Case-Based Practical Guidelines to Challenging CasesJason Liu, Baho Sidiqi, Kyra McComas, et al.
Pancreas|May 21, 2021
Liver Metastasis-Directed Ablative Radiotherapy in Pancreatic Cancer Offers Prolonged Time Off Systemic Therapy in Selected Patients: Data From a Multi-institutional Retrospective StudyGrace Lee, Daniel W Kim, Oluwadamilola T Oladeru, et al.
Annals of Surgical Oncology|February 15, 2023
Validation of a Resectability Scoring System for Prediction of Pancreatic Adenocarcinoma Surgical OutcomesDiego A S Toesca, Matthew Susko, Rie von Eyben, et al.
American Journal of Clinical Oncology|September 17, 2021
Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative RadiotherapyKathryn R K Benson, Navjot Sandhu, Carrie Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 2015
Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicityErqi L Pollom, Muthuraman Alagappan, Rie von Eyben, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 7, 2012
Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic featuresDaniel T Chang, Rish K Pai, Lisa A Rybicki, et al.
Practical Radiation Oncology|November 26, 2019
Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) Guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT)Andrew Oar, Mark Lee, Hien Le, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2021
Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic AdenocarcinomaWilliam A Hall, Laura A Dawson, Theodore S Hong, et al.
Practical Radiation Oncology|November 27, 2024
Radiation Therapy for Rectal Cancer: An ASTRO Clinical Practice Guideline Focused UpdateJennifer Y Wo, Jonathan B Ashman, Nishin A Bhadkamkar, et al.
Annals of Surgery|December 16, 2024
Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which is Best?M Usman Ahmad, Christopher S Javadi, Julia D Chang, et al.
Pageof 23

Showing results (181-190 of 224) with videos related to

Sort By:
Pageof 23
Practical Radiation Oncology|July 10, 2024
SBRT for Pancreatic Cancer: A Radiosurgery Society Case-Based Practical Guidelines to Challenging CasesJason Liu, Baho Sidiqi, Kyra McComas, et al.
Pancreas|May 21, 2021
Liver Metastasis-Directed Ablative Radiotherapy in Pancreatic Cancer Offers Prolonged Time Off Systemic Therapy in Selected Patients: Data From a Multi-institutional Retrospective StudyGrace Lee, Daniel W Kim, Oluwadamilola T Oladeru, et al.
Annals of Surgical Oncology|February 15, 2023
Validation of a Resectability Scoring System for Prediction of Pancreatic Adenocarcinoma Surgical OutcomesDiego A S Toesca, Matthew Susko, Rie von Eyben, et al.
American Journal of Clinical Oncology|September 17, 2021
Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative RadiotherapyKathryn R K Benson, Navjot Sandhu, Carrie Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 2015
Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicityErqi L Pollom, Muthuraman Alagappan, Rie von Eyben, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 7, 2012
Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic featuresDaniel T Chang, Rish K Pai, Lisa A Rybicki, et al.
Practical Radiation Oncology|November 26, 2019
Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) Guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT)Andrew Oar, Mark Lee, Hien Le, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2021
Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic AdenocarcinomaWilliam A Hall, Laura A Dawson, Theodore S Hong, et al.
Practical Radiation Oncology|November 27, 2024
Radiation Therapy for Rectal Cancer: An ASTRO Clinical Practice Guideline Focused UpdateJennifer Y Wo, Jonathan B Ashman, Nishin A Bhadkamkar, et al.
Annals of Surgery|December 16, 2024
Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which is Best?M Usman Ahmad, Christopher S Javadi, Julia D Chang, et al.
Pageof 23